CTNM (NASDAQ) notice to sell 28,826 shares; broker Morgan Stanley named

Rhea-AI Filing Summary

CTNM submitted a notice to sell 28,826 shares of Common Stock. The filing lists the method as an Exercise of Stock Options with proceeds shown as $432,390.00 and identifies the broker as Morgan Stanley Smith Barney LLC. Shares outstanding were 32,723,877 as of 06/30/2026. The filing also discloses recent 10b5-1 sales by Daniel Lorrain of 4,170 shares on 04/06/2026, 05/01/2026, and 06/01/2026 with aggregate proceeds shown for each sale.

Insights

Securities Compliance Analyst

Form 144 documents a proposed resale of shares following option exercise and recent 10b5-1 activity.

The filing lists 28,826 shares to be sold via an Exercise of Stock Options, with an aggregate figure of $432,390.00. It names Morgan Stanley Smith Barney LLC as broker and records the company's outstanding shares as 32,723,877 as of 06/30/2026.

Prior transactions show three 10b5-1 sales of 4,170 shares each on 04/06/2026, 05/01/2026, and 06/01/2026. Subsequent filings will show whether these proposed sales are executed and whether any additional disclosures are required.

Key Figures

Registered/offered shares: 28,826 shares Aggregate proceeds shown: $432,390.00 Shares outstanding: 32,723,877 shares +3 more

6 metrics

Registered/offered shares 28,826 shares listed in Securities To Be Sold row dated <date>06/30/2026</date>

Aggregate proceeds shown $432,390.00 appears on the same row as the 28,826 shares

Shares outstanding 32,723,877 shares as of <date>06/30/2026</date>

Prior 10b5-1 sale (Apr) 4,170 shares <date>04/06/2026</date> sale by Daniel Lorrain, proceeds <money>$56,013.94</money>

Prior 10b5-1 sale (May) 4,170 shares <date>05/01/2026</date> sale by Daniel Lorrain, proceeds <money>$54,707.48</money>

Prior 10b5-1 sale (Jun) 4,170 shares <date>06/01/2026</date> sale by Daniel Lorrain, proceeds <money>$54,862.19</money>

Key Terms

Form 144, 10b5-1, Exercise of Stock Options, Broker

4 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 regulatory

"10b5-1 Sales for DANIEL LORRAIN 3565 General Atomics Court"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"Securities To Be Sold | Exercise of Stock Options"

Broker market

"Common | Morgan Stanley Smith Barney LLC Executive Financial Services"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 06/30/2026 - 04:39 PM Accepted by SEC EDGAR 06/30/2026 - 04:38 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	28826	432390.00	32723877	06/30/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/30/2026	Exercise of Stock Options	Issuer			28826	06/30/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for DANIEL LORRAIN 3565 General Atomics Court, Suite 200 San Diego CA 92121	Common	06/01/2026	4170	54862.19
10b5-1 Sales for DANIEL LORRAIN 3565 General Atomics Court, Suite 200 San Diego CA 92121	Common	05/01/2026	4170	54707.48
10b5-1 Sales for DANIEL LORRAIN 3565 General Atomics Court, Suite 200 San Diego CA 92121	Common	04/06/2026	4170	56013.94

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does CTNM's Form 144 disclose about the number of shares being sold?

The filing discloses a proposed sale of 28,826 shares of Common Stock. This amount is listed alongside an aggregate proceeds figure of $432,390.00 and the broker name in the notice.

Who is identified as the broker and what is the sales method in CTNM's filing?

The filing names Morgan Stanley Smith Barney LLC as the broker and lists the transaction type as an Exercise of Stock Options, with the payment method shown as Cash on 06/30/2026.

Does the Form 144 show recent insider sales for CTNM?

Yes. It reports three prior 10b5-1 sales by Daniel Lorrain of 4,170 shares each on 04/06/2026, 05/01/2026, and 06/01/2026, with per‑sale proceeds listed in the excerpt.

What baseline share count is provided in the CTNM excerpt?

The excerpt lists total shares outstanding as 32,723,877 as of 06/30/2026. That figure appears on the same row as the sale data and provides a company capitalization context.